Stock listing
NASDAQ:ISPH Inspire Pharmaceuticals Inc Stock
Follow Inspire Pharmaceuticals Inc into a list and get an email when it puts out news.
Last close · NASDAQ:ISPH
$5.01 USD
Close on May 16, 2011 · No longer trades
- Lowest – highest close
- $1.99 – $31.50 USDSince Aug 3, 2000 · lowest Oct 10, 2008 · highest Nov 7, 2000
Delisted NASDAQ:ISPH no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:ISPH
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Inspire Pharmaceuticals Inc on 6ix
- Decks
- 5 decks · latest Sep 22, 2009
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| UBS Global Life Sciences Conference 2009 | Conference | 33 slides | Sep 22, 2009 |
| Corporate Update (January 2009) | Corporate update | 11 slides | Jan 27, 2009 |
| Technical Presentation (October 2008) | Technical | 28 slides | Oct 24, 2008 |
| CEUT Emerging Growth Conference 2007 | Conference | 26 slides | Jul 11, 2007 |
| Investor Day (March 2006) | Investor day | 105 slides | Mar 21, 2006 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| William R Ringo Other companies: Assembly Biosciences, Inc. (Director · Since at least Jul 10, 2014); Sensei Biotherapeutics, Inc. (Director · Mar 8, 2022 – May 21, 2025 · Past); Five Prime Therapeutics Inc (Director · Oct 1, 2014 – Apr 5, 2021 · Past); Immune Design Corp (Director · Jul 23, 2014 – Apr 2, 2019 · Past); Onyx Pharmaceuticals Inc (Director · Feb 3, 2011 – Oct 1, 2013 · Past); Sangamo Therapeutics, Inc. (Director · Apr 16, 2010 – Sep 20, 2017 · Past); Pfizer, Inc. (Senior Vice President · Apr 1, 2008 – Mar 31, 2010 · Past); Allos Therapeutics Inc (Director · Jan 5, 2007 – Jun 19, 2007 · Past); Abgenix Inc (CEO and President, Director · Apr 1, 2006 – Apr 1, 2006 · Past); InterMune Inc (Director · Feb 23, 2006 – May 15, 2007 · Past) | Director · Jun 13, 2006 – Jun 8, 2007 · Past |
| Nancy J Hutson Other companies: BioCryst Pharmaceuticals, Inc. (Director · Since at least Jan 20, 2012); Clearside Biomedical Inc (Director · Apr 21, 2020 – Jun 20, 2024 · Past); PhaseBio Pharmaceuticals Inc (Director · Oct 17, 2018 – May 19, 2023 · Past); Endo International PLC (Director · Feb 28, 2014 – Jun 11, 2021 · Past); Cubist Pharmaceuticals Inc (Director · Jun 12, 2008 – Jan 21, 2015 · Past) | Director · Oct 27, 2006 – May 13, 2011 · Past |
| Thomas R Staab II Other companies: Tenax Therapeutics, Inc. (Chief Financial Officer · Since at least May 11, 2026); LENSAR, Inc. (Chief Financial Officer · Since at least Sep 17, 2020); BioCryst Pharmaceuticals, Inc. (Senior Vice President and CFO · Jul 1, 2011 – Feb 21, 2020 · Past) | EVP, CFO & Treasurer · Jan 19, 2006 – May 13, 2011 · Past |
| Richard S Kent Other companies: Nuo Therapeutics Inc (Director · Feb 8, 2012 – Jan 28, 2014 · Past); Cempra Inc (Director · Feb 2, 2012 – Jan 3, 2017 · Past) | Director · Jun 13, 2006 – May 13, 2011 · Past |
| Romulus K Brazzell Other companies: Kala Bio, Inc. (SEE REMARKS · Since at least Jul 19, 2017) | EVP, Medical & Scientific · Jan 19, 2006 – May 13, 2011 · Past |
| Charles A Johnson | EVP of R&D & Chief Med. Ofcr. · Sep 15, 2010 – May 13, 2011 · Past |
| Kip Frey | Director · Nov 10, 2008 – May 13, 2011 · Past |
Log in to ask 6ix AI your own questions about Inspire Pharmaceuticals Inc.